Skip to main content
Top
Published in: Cardiovascular Diabetology 1/2015

Open Access 01-12-2015 | Original investigation

Coronary microvascular function is independently associated with left ventricular filling pressure in patients with type 2 diabetes mellitus

Authors: Takayuki Kawata, Masao Daimon, Sakiko Miyazaki, Ryoko Ichikawa, Masaki Maruyama, Shuo-Ju Chiang, Chiharu Ito, Fumihiko Sato, Hirotaka Watada, Hiroyuki Daida

Published in: Cardiovascular Diabetology | Issue 1/2015

Login to get access

Abstract

Background

Left ventricular (LV) diastolic dysfunction is known as an early marker of myocardial alterations in patients with diabetes. Because microvascular disease has been regarded as an important cause of heart failure or diastolic dysfunction in diabetic patients, we tested the hypothesis that coronary flow reserve (CFR), which reflects coronary microvascular function, is associated with LV diastolic dysfunction in patients with type 2 diabetes.

Methods

We studied asymptomatic patients with type 2 diabetes but without overt heart failure. Transthoracic Doppler echocardiography was performed that included pulsed tissue Doppler of the mitral annulus and CFR of the left anterior descending artery (induced by adenosine 0.14 mg/kg/min). The ratio of mitral velocity to early diastolic velocity of the mitral annulus (E/e′) was used as a surrogate marker of diastolic function. We also evaluated renal function, lipid profile, parameters of glycemic control and other clinical characteristics to determine their association with E/e′. Patients with LV ejection fraction <50%, atrial fibrillation, valvular disease, regional wall motion abnormality, renal failure (serum creatinine >2.0 mg/dl) or type 1 diabetes were excluded. Patients with a CFR <2.0 were also excluded based on the suspicion of significant coronary artery stenosis.

Results

We included 67 asymptomatic patients with type 2 diabetes and 14 non-diabetic controls in the final study population. In univariate analysis, age, presence of hypertension, LV mass index, estimated glomerular filtration rate and CFR were significantly associated with E/e′. Multivariate analysis indicated that both LV mass index and CFR were independently associated with E/e′. In contrast, there were no significant associations between parameters of glycemic control and E/e′.

Conclusions

CFR was associated with LV filling pressure in patients with type 2 diabetes. This result suggests a possible link between coronary microvascular disease and LV diastolic function in these subjects.
Literature
1.
go back to reference Fagan TC, Sowers J (1999) Type 2 diabetes mellitus: greater cardiovascular risks and greater benefits of therapy. Arch Intern Med 159:1033–1034PubMedCrossRef Fagan TC, Sowers J (1999) Type 2 diabetes mellitus: greater cardiovascular risks and greater benefits of therapy. Arch Intern Med 159:1033–1034PubMedCrossRef
2.
go back to reference Kannel WB, Hjortland M, Castelli WP (1974) Role of diabetes in congestive heart failure: the Framingham study. Am J Cardiol 34:29–34PubMedCrossRef Kannel WB, Hjortland M, Castelli WP (1974) Role of diabetes in congestive heart failure: the Framingham study. Am J Cardiol 34:29–34PubMedCrossRef
3.
go back to reference Galderisi M, Anderson KM, Wilson PW, Levy D (1991) Echocardiographic evidence for the existence of a distinct diabetic cardiomyopathy (the Framingham Heart Study). Am J Cardiol 68:85–89PubMedCrossRef Galderisi M, Anderson KM, Wilson PW, Levy D (1991) Echocardiographic evidence for the existence of a distinct diabetic cardiomyopathy (the Framingham Heart Study). Am J Cardiol 68:85–89PubMedCrossRef
4.
go back to reference Lee M, Gardin JM, Lynch JC, Smith VE, Tracy RP, Savage PJ et al (1997) Diabetes mellitus and echocardiographic left ventricular function in free-living elderly men and women. The Cardiovascular Health Study. Am Heart J 133:36–43PubMedCrossRef Lee M, Gardin JM, Lynch JC, Smith VE, Tracy RP, Savage PJ et al (1997) Diabetes mellitus and echocardiographic left ventricular function in free-living elderly men and women. The Cardiovascular Health Study. Am Heart J 133:36–43PubMedCrossRef
5.
go back to reference Devereux RB, Roman MJ, Paranicas M, O’Grady MJ, Lee ET, Welty TK et al (2000) Impact of diabetes on cardiac structure and function: the Strong Heart Study. Circulation 101:2271–2276PubMedCrossRef Devereux RB, Roman MJ, Paranicas M, O’Grady MJ, Lee ET, Welty TK et al (2000) Impact of diabetes on cardiac structure and function: the Strong Heart Study. Circulation 101:2271–2276PubMedCrossRef
6.
go back to reference Liu JE, Palmieri V, Roman MJ, Bella JN, Fabsitz R, Howard BV et al (2001) The impact of diabetes on left ventricular filling pattern in normotensive and hypertensive adults: the Strong Heart Study. J Am Coll Cardiol 37:1943–1949PubMedCrossRef Liu JE, Palmieri V, Roman MJ, Bella JN, Fabsitz R, Howard BV et al (2001) The impact of diabetes on left ventricular filling pattern in normotensive and hypertensive adults: the Strong Heart Study. J Am Coll Cardiol 37:1943–1949PubMedCrossRef
7.
go back to reference Boyer JK, Thanigaraj S, Schechtman KB, Perez JE (2004) Prevalence of ventricular diastolic dysfunction in asymptomatic, normotensive patients with diabetes mellitus. Am J Cardiol 93:870–875PubMedCrossRef Boyer JK, Thanigaraj S, Schechtman KB, Perez JE (2004) Prevalence of ventricular diastolic dysfunction in asymptomatic, normotensive patients with diabetes mellitus. Am J Cardiol 93:870–875PubMedCrossRef
9.
go back to reference From AM, Scott CG, Chen HH (2010) The development of heart failure in patients with diabetes mellitus and preclinical diastolic dysfunction a population-based study. J Am Coll Cardiol 55:300–305PubMedCrossRef From AM, Scott CG, Chen HH (2010) The development of heart failure in patients with diabetes mellitus and preclinical diastolic dysfunction a population-based study. J Am Coll Cardiol 55:300–305PubMedCrossRef
10.
go back to reference Kiencke S, Handschin R, von Dahlen R, Muser J, Brunner-Larocca HP, Schumann J et al (2010) Preclinical diabetic cardiomyopathy: prevalence, screening, and outcome. Eur J Heart Fail 12:951–957PubMedCrossRef Kiencke S, Handschin R, von Dahlen R, Muser J, Brunner-Larocca HP, Schumann J et al (2010) Preclinical diabetic cardiomyopathy: prevalence, screening, and outcome. Eur J Heart Fail 12:951–957PubMedCrossRef
12.
go back to reference Galderisi M (2006) Diastolic dysfunction and diabetic cardiomyopathy: evaluation by Doppler echocardiography. J Am Coll Cardiol 48:1548–1551PubMedCrossRef Galderisi M (2006) Diastolic dysfunction and diabetic cardiomyopathy: evaluation by Doppler echocardiography. J Am Coll Cardiol 48:1548–1551PubMedCrossRef
13.
go back to reference Cheung N, Wang JJ, Rogers SL, Brancati F, Klein R, Sharrett AR et al (2008) Diabetic retinopathy and risk of heart failure. J Am Coll Cardiol 51:1573–1578PubMedCrossRef Cheung N, Wang JJ, Rogers SL, Brancati F, Klein R, Sharrett AR et al (2008) Diabetic retinopathy and risk of heart failure. J Am Coll Cardiol 51:1573–1578PubMedCrossRef
14.
go back to reference Takeda Y, Sakata Y, Mano T, Ohtani T, Tamaki S, Omori Y et al (2011) Diabetic retinopathy is associated with impaired left ventricular relaxation. J Card Fail 17:556–560PubMedCrossRef Takeda Y, Sakata Y, Mano T, Ohtani T, Tamaki S, Omori Y et al (2011) Diabetic retinopathy is associated with impaired left ventricular relaxation. J Card Fail 17:556–560PubMedCrossRef
15.
go back to reference Akasaka T, Yoshida K, Hozumi T, Takagi T, Kaji S, Kawamoto T et al (1997) Retinopathy identifies marked restriction of coronary flow reserve in patients with diabetes mellitus. J Am Coll Cardiol 30:935–941PubMedCrossRef Akasaka T, Yoshida K, Hozumi T, Takagi T, Kaji S, Kawamoto T et al (1997) Retinopathy identifies marked restriction of coronary flow reserve in patients with diabetes mellitus. J Am Coll Cardiol 30:935–941PubMedCrossRef
16.
17.
go back to reference Kawata T, Daimon M, Hasegawa R, Toyoda T, Sekine T, Himi T et al (2013) Prognostic value of coronary flow reserve assessed by transthoracic Doppler echocardiography on long-term outcome in asymptomatic patients with type 2 diabetes without overt coronary artery disease. Cardiovasc Diabetol 12:121PubMedCentralPubMedCrossRef Kawata T, Daimon M, Hasegawa R, Toyoda T, Sekine T, Himi T et al (2013) Prognostic value of coronary flow reserve assessed by transthoracic Doppler echocardiography on long-term outcome in asymptomatic patients with type 2 diabetes without overt coronary artery disease. Cardiovasc Diabetol 12:121PubMedCentralPubMedCrossRef
18.
go back to reference Erdogan D, Yildirim I, Ciftci O, Ozer I, Caliskan M, Gullu H et al (2007) Effects of normal blood pressure, prehypertension, and hypertension on coronary microvascular function. Circulation 115:593–599PubMedCrossRef Erdogan D, Yildirim I, Ciftci O, Ozer I, Caliskan M, Gullu H et al (2007) Effects of normal blood pressure, prehypertension, and hypertension on coronary microvascular function. Circulation 115:593–599PubMedCrossRef
19.
go back to reference Tona F, Serra R, Di Ascenzo L, Osto E, Scarda A, Fabris R et al (2014) Systemic inflammation is related to coronary microvascular dysfunction in obese patients without obstructive coronary disease. Nutr Metab Cardiovasc Dis 24:447–453PubMedCrossRef Tona F, Serra R, Di Ascenzo L, Osto E, Scarda A, Fabris R et al (2014) Systemic inflammation is related to coronary microvascular dysfunction in obese patients without obstructive coronary disease. Nutr Metab Cardiovasc Dis 24:447–453PubMedCrossRef
20.
go back to reference Erdogan D, Akcay S, Yucel H, Ersoy IH, Icli A, Kutlucan A et al (2015) The effects of good glycaemic control on left ventricular and coronary endothelial functions in patients with poorly controlled Type 2 diabetes mellitus. Clin Endocrinol 82:388–396CrossRef Erdogan D, Akcay S, Yucel H, Ersoy IH, Icli A, Kutlucan A et al (2015) The effects of good glycaemic control on left ventricular and coronary endothelial functions in patients with poorly controlled Type 2 diabetes mellitus. Clin Endocrinol 82:388–396CrossRef
21.
go back to reference D’Andrea A, Nistri S, Castaldo F, Galderisi M, Mele D, Agricola E et al (2012) The relationship between early left ventricular myocardial alterations and reduced coronary flow reserve in non-insulin-dependent diabetic patients with microvascular angina. Int J Cardiol 154:250–255PubMedCrossRef D’Andrea A, Nistri S, Castaldo F, Galderisi M, Mele D, Agricola E et al (2012) The relationship between early left ventricular myocardial alterations and reduced coronary flow reserve in non-insulin-dependent diabetic patients with microvascular angina. Int J Cardiol 154:250–255PubMedCrossRef
22.
go back to reference Hozumi T, Yoshida K, Akasaka T, Asami Y, Ogata Y, Takagi T et al (1998) Noninvasive assessment of coronary flow velocity and coronary flow velocity reserve in the left anterior descending coronary artery by Doppler echocardiography: comparison with invasive technique. J Am Coll Cardiol 32:1251–1259PubMedCrossRef Hozumi T, Yoshida K, Akasaka T, Asami Y, Ogata Y, Takagi T et al (1998) Noninvasive assessment of coronary flow velocity and coronary flow velocity reserve in the left anterior descending coronary artery by Doppler echocardiography: comparison with invasive technique. J Am Coll Cardiol 32:1251–1259PubMedCrossRef
23.
go back to reference Daimon M, Watanabe H, Yamagishi H, Muro T, Akioka K, Hirata K et al (2001) Physiologic assessment of coronary artery stenosis by coronary flow reserve measurements with transthoracic Doppler echocardiography: comparison with exercise thallium-201 single piston emission computed tomography. J Am Coll Cardiol 37:1310–1315PubMedCrossRef Daimon M, Watanabe H, Yamagishi H, Muro T, Akioka K, Hirata K et al (2001) Physiologic assessment of coronary artery stenosis by coronary flow reserve measurements with transthoracic Doppler echocardiography: comparison with exercise thallium-201 single piston emission computed tomography. J Am Coll Cardiol 37:1310–1315PubMedCrossRef
24.
go back to reference World Health Organization (1999) Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO consultation. World Health Organization, Geneva World Health Organization (1999) Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO consultation. World Health Organization, Geneva
25.
go back to reference Cohn PF, Vokonas PS, Herman MV, Gorlin R (1971) Postexercise electrocardiogram in patients with abnormal resting electrocardiograms. Circulation 43:648–654PubMedCrossRef Cohn PF, Vokonas PS, Herman MV, Gorlin R (1971) Postexercise electrocardiogram in patients with abnormal resting electrocardiograms. Circulation 43:648–654PubMedCrossRef
26.
go back to reference Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA et al (2005) Recommendations for chamber quantification: a report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 18:1440–1463PubMedCrossRef Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA et al (2005) Recommendations for chamber quantification: a report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 18:1440–1463PubMedCrossRef
27.
go back to reference Nagueh SF, Appleton CP, Gillebert TC, Marino PN, Oh JK, Smiseth OA et al (2009) Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J Am Soc Echocardiogr 22:107–133PubMedCrossRef Nagueh SF, Appleton CP, Gillebert TC, Marino PN, Oh JK, Smiseth OA et al (2009) Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J Am Soc Echocardiogr 22:107–133PubMedCrossRef
28.
go back to reference Canepa M, Strait JB, Abramov D, Milaneschi Y, AlGhatrif M, Moni M et al (2012) Contribution of central adiposity to left ventricular diastolic function (from the Baltimore Longitudinal Study of Aging). Am J Cardiol 109:1171–1178PubMedCentralPubMedCrossRef Canepa M, Strait JB, Abramov D, Milaneschi Y, AlGhatrif M, Moni M et al (2012) Contribution of central adiposity to left ventricular diastolic function (from the Baltimore Longitudinal Study of Aging). Am J Cardiol 109:1171–1178PubMedCentralPubMedCrossRef
29.
go back to reference Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419PubMedCrossRef Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419PubMedCrossRef
30.
go back to reference Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K et al (2009) Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 53:982–992PubMedCrossRef Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K et al (2009) Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 53:982–992PubMedCrossRef
31.
go back to reference Dinneen SF, Gerstein HC (1997) The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus; a systematic overview of the literature. Arch Intern Med 157:1413–1418PubMedCrossRef Dinneen SF, Gerstein HC (1997) The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus; a systematic overview of the literature. Arch Intern Med 157:1413–1418PubMedCrossRef
32.
go back to reference Fang ZY, Prins JB, Marwick TH (2004) Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications. Endocr Rev 25:543–567PubMedCrossRef Fang ZY, Prins JB, Marwick TH (2004) Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications. Endocr Rev 25:543–567PubMedCrossRef
33.
go back to reference Mourmoura E, Vial G, Laillet B, Rigaudière JP, Hininger-Favier I, Dubouchaud H et al (2013) Preserved endothelium-dependent dilatation of the coronary microvasculature at the early phase of diabetes mellitus despite the increased oxidative stress and depressed cardiac mechanical function ex vivo. Cardiovasc Diabetol 12:49PubMedCentralPubMedCrossRef Mourmoura E, Vial G, Laillet B, Rigaudière JP, Hininger-Favier I, Dubouchaud H et al (2013) Preserved endothelium-dependent dilatation of the coronary microvasculature at the early phase of diabetes mellitus despite the increased oxidative stress and depressed cardiac mechanical function ex vivo. Cardiovasc Diabetol 12:49PubMedCentralPubMedCrossRef
34.
go back to reference Belardinelli L, Linden J, Berne RM (1989) The cardiac effects of adenosine. Prog Cardiovasc Dis 32:73–97PubMedCrossRef Belardinelli L, Linden J, Berne RM (1989) The cardiac effects of adenosine. Prog Cardiovasc Dis 32:73–97PubMedCrossRef
35.
go back to reference Smith P, Williams SB, Lipson DE, Banitt P, Rongen GA, Creager MA (1995) Endothelial release of nitric oxide contributes to the vasodilator effect of adenosine in humans. Circulation 92:2135–2141CrossRef Smith P, Williams SB, Lipson DE, Banitt P, Rongen GA, Creager MA (1995) Endothelial release of nitric oxide contributes to the vasodilator effect of adenosine in humans. Circulation 92:2135–2141CrossRef
36.
go back to reference Buus NH, Bøttcher M, Hermansen F, Sander M, Nielsen TT, Mulvany MJ (2001) Influence of nitric oxide synthase and adrenergic inhibition on adenosine-induced myocardial hyperemia. Circulation 104:2305–2310PubMedCrossRef Buus NH, Bøttcher M, Hermansen F, Sander M, Nielsen TT, Mulvany MJ (2001) Influence of nitric oxide synthase and adrenergic inhibition on adenosine-induced myocardial hyperemia. Circulation 104:2305–2310PubMedCrossRef
37.
go back to reference Kawata T, Daimon M, Hasegawa R, Teramoto K, Toyoda T, Sekine T et al (2005) Serum asymmetric dimethylarginine as a marker of coronary microcirculation in patients with non-insulin dependent diabetes mellitus: correlation with coronary flow reserve. Heart 91:1607–1608PubMedCentralPubMedCrossRef Kawata T, Daimon M, Hasegawa R, Teramoto K, Toyoda T, Sekine T et al (2005) Serum asymmetric dimethylarginine as a marker of coronary microcirculation in patients with non-insulin dependent diabetes mellitus: correlation with coronary flow reserve. Heart 91:1607–1608PubMedCentralPubMedCrossRef
38.
go back to reference Paulus WJ, Tschöpe C (2013) A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. J Am Coll Cardiol 62:263–271PubMedCrossRef Paulus WJ, Tschöpe C (2013) A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. J Am Coll Cardiol 62:263–271PubMedCrossRef
39.
go back to reference Stahrenberg R, Edelmann F, Mende M, Kockskämper A, Düngen HD, Scherer M et al (2010) Association of glucose metabolism with diastolic function along the diabetic continuum. Diabetologia 53:1331–1340PubMedCentralPubMedCrossRef Stahrenberg R, Edelmann F, Mende M, Kockskämper A, Düngen HD, Scherer M et al (2010) Association of glucose metabolism with diastolic function along the diabetic continuum. Diabetologia 53:1331–1340PubMedCentralPubMedCrossRef
40.
go back to reference Gerstein HC, Mann JF, Yi Q, Zinman B, Dinneen SF, Hoogwerf B et al (2001) Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 286:421–426PubMedCrossRef Gerstein HC, Mann JF, Yi Q, Zinman B, Dinneen SF, Hoogwerf B et al (2001) Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 286:421–426PubMedCrossRef
41.
go back to reference Galderisi M, Cicala S, Caso P, De Simone L, D’Errico A, Petrocelli A et al (2002) Coronary flow reserve and myocardial diastolic dysfunction in arterial hypertension. Am J Cardiol 90:860–864PubMedCrossRef Galderisi M, Cicala S, Caso P, De Simone L, D’Errico A, Petrocelli A et al (2002) Coronary flow reserve and myocardial diastolic dysfunction in arterial hypertension. Am J Cardiol 90:860–864PubMedCrossRef
42.
go back to reference Snoer M, Olsen RH, Monk-Hansen T, Pedersen LR, Haugaard SB, Dela F et al (2014) Coronary flow reserve predicts cardiopulmonary fitness in patients with coronary artery disease independently of systolic and diastolic function. Echocardiography 31:654–662PubMedCrossRef Snoer M, Olsen RH, Monk-Hansen T, Pedersen LR, Haugaard SB, Dela F et al (2014) Coronary flow reserve predicts cardiopulmonary fitness in patients with coronary artery disease independently of systolic and diastolic function. Echocardiography 31:654–662PubMedCrossRef
43.
go back to reference Matsumura Y, Hozumi T, Watanabe H, Fujimoto K, Sugioka K, Takemoto Y et al (2003) Cut-off value of coronary flow velocity reserve by transthoracic Doppler echocardiography for diagnosis of significant left anterior descending artery stenosis in patients with coronary risk factors. Am J Cardiol 92:1389–1393PubMedCrossRef Matsumura Y, Hozumi T, Watanabe H, Fujimoto K, Sugioka K, Takemoto Y et al (2003) Cut-off value of coronary flow velocity reserve by transthoracic Doppler echocardiography for diagnosis of significant left anterior descending artery stenosis in patients with coronary risk factors. Am J Cardiol 92:1389–1393PubMedCrossRef
44.
Metadata
Title
Coronary microvascular function is independently associated with left ventricular filling pressure in patients with type 2 diabetes mellitus
Authors
Takayuki Kawata
Masao Daimon
Sakiko Miyazaki
Ryoko Ichikawa
Masaki Maruyama
Shuo-Ju Chiang
Chiharu Ito
Fumihiko Sato
Hirotaka Watada
Hiroyuki Daida
Publication date
01-12-2015
Publisher
BioMed Central
Published in
Cardiovascular Diabetology / Issue 1/2015
Electronic ISSN: 1475-2840
DOI
https://doi.org/10.1186/s12933-015-0263-7

Other articles of this Issue 1/2015

Cardiovascular Diabetology 1/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.